Executive Medical Director, Clinical Development, Advanced Pipeline Unit (apu) Respiratory
GSK
PA, US
Base: $284,625 to $474,375 (us); bonus/equity: ann...
Clinical development strategy leadership
Interstitial lung diseases (ild) expertise
Late-stage drug development experience
Provide clinical and scientific leadership for potential new, established and emerging indications for assets in clinical development with a strong focus on Interstitial Lung Diseases (ILD)
Job Summary
Provide clinical and scientific leadership for potential new, established and emerging indications for assets in clinical development with a strong focus on Interstitial Lung Diseases (ILD).
Lead the clinical development strategy from a drug or program including accountability for the clinical components of the Target Medicine Profile (TMP) and leadership of the clinical matrix team (CMT).
Manage technical and leadership development of Clinical Development staff via direct line management, mentoring and coaching across the organisation.
Matching Summary
Provide clinical and scientific leadership for potential new, established and emerging indications for assets in clinical development with a strong focus on Interstitial Lung Diseases (ILD).
Salary
Base: $284,625 to $474,375 (US); Bonus/Equity: Annual bonus and eligibility for long-term incentive program; Benefits: Health care, insurance, retirement, paid time off
Skills & Requirements
Must-have
Clinical development strategy leadership
Interstitial Lung Diseases (ILD) expertise
Late-stage drug development experience
Global regulatory submissions management
Matrix team leadership
Nice-to-have
Inspire and empower teams
Innovative methodologies and processes
Enterprise mindset
Strategic thinking and problem-solving
Key Requirements
Medical degree and clinical medical specialty training board qualification/registration
Experience in global pharmaceutical/biotechnology industry
Experience in Interstitial Lung Diseases (ILD)
Experience in Idiopathic pulmonary Fibrosis (IPF)
Experience in Progressive Pulmonary Fibrosis (PPF)
Experience in autoimmune associated ILDs
Experience in late-stage Lung Disease drug development
Experience in Phase 2 and Phase 3 clinical trial design